DPM3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.549200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.026400E-01
Normal-vs-Stage2
7.429200E-01
Normal-vs-Stage3
9.450200E-01
Normal-vs-Stage4
6.904400E-02
Stage1-vs-Stage2
1.223000E-01
Stage1-vs-Stage3
2.755800E-01
Stage1-vs-Stage4
4.306800E-01
Stage2-vs-Stage3
6.698400E-01
Stage2-vs-Stage4
2.756600E-01
Stage3-vs-Stage4
2.548000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.582600E-01
Normal-vs-AfricanAmerican
2.499800E-01
Normal-vs-Asian
1.303250E-01
Caucasian-vs-AfricanAmerican
3.924000E-01
Caucasian-vs-Asian
1.858350E-01
AfricanAmerican-vs-Asian
5.664800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.271450E-01
Normal-vs-Female
5.683600E-01
Male-vs-Female
9.137200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.750200E-01
Normal-vs-Age(41-60Yrs)
7.617200E-01
Normal-vs-Age(61-80Yrs)
4.758400E-02
Normal-vs-Age(81-100Yrs)
7.091200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.147400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.164800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.108200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.212200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.456400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.380420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.090800E-01
Normal-vs-Daily Drinker
3.430000E-01
Normal-vs-Weekly Drinker
3.276600E-01
Normal-vs-Occasional Drinker
5.505200E-01
Normal-vs-Social Drinker
7.610200E-01
Non Drinker-vs-Daily Drinker
2.502200E-01
Non Drinker-vs-Weekly Drinker
5.065800E-01
Non Drinker-vs-Occasional Drinker
5.654600E-01
Non Drinker-vs-Social Drinker
8.626200E-01
Daily Drinker-vs-Weekly Drinker
7.688800E-01
Daily Drinker-vs-Occasional Drinker
7.189800E-01
Daily Drinker-vs-Social Drinker
3.188800E-01
Weekly Drinker-vs-Occasional Drinker
6.638800E-01
Weekly Drinker-vs-Social Drinker
4.847400E-01
Occasional Drinker-vs-Social Drinker
5.832800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.310000E-01
Normal-vs-Grade 2
3.241200E-01
Normal-vs-Grade 3
5.582000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.070400E-02
Grade 1-vs-Grade 3
4.900100E-03
Grade 1-vs-Grade 4
3.310000E-01
Grade 2-vs-Grade 3
6.055800E-03
Grade 2-vs-Grade 4
3.241200E-01
Grade 3-vs-Grade 4
5.582000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.669400E-01
Normal-vs-NonDiabetic
3.474300E-02
Diabetic-vs-NonDiabetic
1.506650E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.653000E-01
Normal-vs-NoPancreatitis
6.467200E-01
Pancreatitis-vs-NoPancreatitis
5.530600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.201800E-01
Normal-vs-N1
7.620800E-01
N0-vs-N1
2.054000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.591200E-01
Normal-vs-TP53-NonMutant
1.485050E-01
TP53-Mutant-vs-TP53-NonMutant
1.854790E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
